Assay News and Research

RSS

Fuse Diagnostics Raises £1 Million to Scale Rapid Point-of-Need Molecular Testing Platform

Fuse Diagnostics (“Fuse”), a developer of next-generation molecular diagnostics for point-of-need testing, today announced it has raised £1 million to accelerate commercialization of its proprietary Flip™ product platform and expand manufacturing capabilities at its headquarters in Cambridge, UK.

16 Sep 2026

Multi-Omic Integration Reveals Novel Gene-Disease Links in Undiagnosed Rare Conditions

Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have shown that measuring proteins in the blood can provide important additional clues about the effects of genetic variants, helping to identify diagnoses and potential new disease-causing genes that genome sequencing alone has been unable to resolve.

10 Sep 2026

Research Identifies Microorganisms That Convert Precursors Into Testosterone

Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects.

7 Sep 2026

Colorectal Cancer and Nerve Damage: A Hidden Link Uncovered in Mice and Primates

Colorectal tumors trigger inflammatory nerve damage, suggesting cancer itself may be a risk factor for neuropathy in survivors, independent of treatments.

27 Aug 2026

Antibodies for Visualizing Cell Identity and Tumor Architecture

Whether you are characterizing cell state transitions, assessing organelle integrity, or building a multiplex immunofluorescence (IF) assay, you need reliable structural markers for your imaging.

From Antibodies Incorporated 21 Aug 2026

DeNovix Releases CellGlow, the Instant Cell Viability Assay

DeNovix Inc. announces the release of CellGlow, a new ready-to-use viability assay for automated cell counting.

From DeNovix Inc. 29 Jul 2026

Deep-Learning Holography Detects Elusive Circulating Tumor Cells in Prostate Cancer

Researchers combined microfluidic enrichment, AI-assisted holography, and fluorescence profiling to identify circulating tumor cell candidates in 13 men with metastatic castration-resistant prostate cancer and 8 healthy donors. The platform found higher median candidate counts in patients, while nearly two-thirds of PSMA-positive candidates lacked EpCAM, suggesting EpCAM-dependent assays could miss some cells.

27 Jul 2026

AI-Assisted Paper Test Measures Three Cardiac Biomarkers in 23 Minutes

Researchers developed an AI-assisted dual-mode paper assay that measures cTnI, CK-MB, and NT-proBNP from 50 µL of serum in 23 minutes. In single-site analytical validation, neural networks quantified the three biomarkers across distinct concentration ranges, supporting further development for multiplexed cardiac testing at the point of care.

27 Jul 2026

arcoris bio and Europa Biosite Partner to Bring immunoMUSE® Kits to Europe and North American Market

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced a distribution partnership with Europa Biosite, a leading distributor of life science research products and services.

From arcoris bio AG 21 Jul 2026

Nature Study Reveals Hidden Genes Driving Hard-to-Treat Tumors

Researchers have solved a long-standing mystery of how abnormal chromosomes drive cancer, identifying 81 new genes involved in aggressive breast cancer.

9 Jul 2026

Countable Labs and Promega Announce Co-Marketing Agreement to Facilitate End-to End Biological Sample Preparation and Rare Variant Detection

Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement with Promega, a leader in providing innovative solutions and technical support to the life sciences industry.

From Promega Corporation 7 Jul 2026

Chinese Researchers Map Greek Oregano Genome for Better Agriculture

Oregano belongs to the Lamiaceae family, which includes many aromatic and medicinal plants.

30 Jun 2026

Novel Cyclic Peptides Cross Cell Membranes to Fight Disease

Many diseases are driven by proteins interacting with each other inside cells. But blocking these interactions with drugs is difficult because our typic "small-molecule" drugs often prove to be too small to grip the broad, flat surfaces involved in protein-protein interactions.

1 Jun 2026

New TriPcide Antibiotics Kill Dormant MRSA Without Resistance

The study on TriPcides reveals their ability to combat MRSA and dormant bacteria, offering a new strategy to address antimicrobial resistance in public health.

27 May 2026

Genomewide CRISPR Screen Reveals Unexpected Structural Protein Link Behind Chronic Colon Inflammation

Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon. But until now, the exact mechanism the toxin uses to latch onto those cells remained a mystery.

25 May 2026

Assay News and Research

Fuse Diagnostics Raises £1 Million to Scale Rapid Point-of-Need Molecular Testing Platform

Multi-Omic Integration Reveals Novel Gene-Disease Links in Undiagnosed Rare Conditions

Research Identifies Microorganisms That Convert Precursors Into Testosterone

Colorectal Cancer and Nerve Damage: A Hidden Link Uncovered in Mice and Primates

Antibodies for Visualizing Cell Identity and Tumor Architecture

DeNovix Releases CellGlow, the Instant Cell Viability Assay

Deep-Learning Holography Detects Elusive Circulating Tumor Cells in Prostate Cancer

AI-Assisted Paper Test Measures Three Cardiac Biomarkers in 23 Minutes

arcoris bio and Europa Biosite Partner to Bring immunoMUSE® Kits to Europe and North American Market

Nature Study Reveals Hidden Genes Driving Hard-to-Treat Tumors

Countable Labs and Promega Announce Co-Marketing Agreement to Facilitate End-to End Biological Sample Preparation and Rare Variant Detection

Chinese Researchers Map Greek Oregano Genome for Better Agriculture

Novel Cyclic Peptides Cross Cell Membranes to Fight Disease

New TriPcide Antibiotics Kill Dormant MRSA Without Resistance

Genomewide CRISPR Screen Reveals Unexpected Structural Protein Link Behind Chronic Colon Inflammation

New 3D Cortical Tissue Models Incorporate Microglia to Bridge Preclinical Translation Gaps

Advanced Genomic Techniques Map Cellular Changes During Brain Aging

New Discovery Reveals How HIV Infects Resting Immune Cells

Accelerating Enzyme Discovery With the SMART Single-Molecule Screening System

Intermediate PRRX1 Levels Drive Breast Cancer Metastasis Risk

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

RecentIndustryFocuses

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics